Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Identification of a novel putative inhibitor of the Plasmodium falciparum purine nucleoside phosphorylase: exploring the purine salvage pathway to design new antimalarial drugs.

Kagami LP, das Neves GM, Rodrigues RP, da Silva VB, Eifler-Lima VL, Kawano DF.

Mol Divers. 2017 May 18. doi: 10.1007/s11030-017-9745-8. [Epub ahead of print]

PMID:
28523625
2.

Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.

da Silva VBR, Campos BRKL, de Oliveira JF, Decout JL, do Carmo Alves de Lima M.

Bioorg Med Chem. 2017 Jul 1;25(13):3259-3277. doi: 10.1016/j.bmc.2017.04.031. Epub 2017 Apr 27. Review.

PMID:
28495384
3.

In silico design of new inhibitors of guanine phosphoribosyltransferase (GPRT) from Giardia lamblia as antiparasitic drug candidates.

das Neves GM, Kagami LP, Rodrigues RP, da Silva VB, Eifler-Lima VL, Kawano DF.

Curr Drug Discov Technol. 2016 Dec 13. [Epub ahead of print]

PMID:
27978783
4.

Mood disorders are highly prevalent but underdiagnosed among patients seeking bariatric surgery.

Da Silva VB, Da Silva RB, Azorin JM, Belzeaux R.

Obes Surg. 2015 Mar;25(3):543-4. doi: 10.1007/s11695-014-1557-7. No abstract available.

PMID:
25589018
5.

Prevalence and clinical features of respiratory syncytial virus in children hospitalized for community-acquired pneumonia in northern Brazil.

Lamarão LM, Ramos FL, Mello WA, Santos MC, Barbagelata LS, Justino MC, da Silva AF, Quaresma AJ, da Silva VB, Burbano RR, Linhares AC.

BMC Infect Dis. 2012 May 16;12:119.

6.

Novel aryl β-aminocarbonyl derivatives as inhibitors of Trypanosoma cruzi trypanothione reductase: binding mode revised by docking and GRIND2-based 3D-QSAR procedures.

de Paula da Silva CH, Bernardes LS, da Silva VB, Zani CL, Carvalho I.

J Biomol Struct Dyn. 2012;29(6):702-16. doi: 10.1080/07391102.2011.672633.

PMID:
22546000
7.

Endo-xylanase GH11 activation by the fungal metabolite eugenitin.

Andrioli WJ, Damásio AR, Silva TM, da Silva VB, Maller A, Nanayakkara NP, Silva CH, Polizeli ML, Bastos JK.

Biotechnol Lett. 2012 Aug;34(8):1487-92. doi: 10.1007/s10529-012-0918-3. Epub 2012 Apr 6.

PMID:
22481300
8.

Optimization of production of extracellular polymeric substances by Arthrobacter viscosus and their interaction with a 13X zeolite for the biosorption of Cr(VI).

Quintelas C, da Silva VB, Silva B, Figueiredo H, Tavares T.

Environ Technol. 2011 Oct;32(13-14):1541-9.

PMID:
22329145
9.
10.

Influence of previous acid etching on interface morphology and bond strength of self-etching adhesive to cavosurface enamel.

Lima AF, da Silva VB, Soares GP, Marchi GM, Baggio Aguiar FH, Lovadino JR.

Eur J Dent. 2012 Jan;6(1):56-62.

11.

In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity.

da Silva VB, de Andrade P, Kawano DF, Morais PA, de Almeida JR, Carvalho I, Taft CA, da Silva CH.

Future Med Chem. 2011 Jun;3(8):947-60. doi: 10.4155/fmc.11.67. Review.

PMID:
21707398
12.

Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.

Justino MC, Linhares AC, Lanzieri TM, Miranda Y, Mascarenhas JD, Abreu E, Guerra SF, Oliveira AS, da Silva VB, Sanchez N, Meyer N, Shafi F, Ortega-Barria E, Soriano-Gabarró M, Colindres RE.

Pediatr Infect Dis J. 2011 May;30(5):396-401. doi: 10.1097/INF.0b013e3182055cc2.

PMID:
21150692
13.

Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyltransferase inhibitors in cancer therapy.

da Silva CH, da Silva VB, Resende J, Rodrigues PF, Bononi FC, Benevenuto CG, Taft CA.

J Mol Graph Model. 2010 Feb 26;28(6):513-23. doi: 10.1016/j.jmgm.2009.11.011. Epub 2009 Dec 4.

PMID:
20074987
14.

Psoralen and bergapten: in silico metabolism and toxicophoric analysis of drugs used to treat vitiligo.

da Silva VB, Kawano DF, Carvalho I, da Conceição EC, de Freitas O, da Silva CH.

J Pharm Pharm Sci. 2009;12(3):378-87.

15.

Pharmacokinetic and pharmacodynamic predictions of novel potential HIV-1 integrase inhibitors.

da Silva CH, da Silva VB, Taft CA.

Drug Metab Lett. 2008 Dec;2(4):256-60.

PMID:
19356102
16.

Molecular dynamics, density functional, ADMET predictions, virtual screening, and molecular interaction field studies for identification and evaluation of novel potential CDK2 inhibitors in cancer therapy.

da Silva VB, Kawano DF, Gomes Ada S, Carvalho I, Taft CA, da Silva CH.

J Phys Chem A. 2008 Sep 25;112(38):8902-10. doi: 10.1021/jp8011969. Epub 2008 Aug 13.

PMID:
18698751
17.

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.

Linhares AC, Velázquez FR, Pérez-Schael I, Sáez-Llorens X, Abate H, Espinoza F, López P, Macías-Parra M, Ortega-Barría E, Rivera-Medina DM, Rivera L, Pavía-Ruz N, Nuñez E, Damaso S, Ruiz-Palacios GM, De Vos B, O'Ryan M, Gillard P, Bouckenooghe A; Human Rotavirus Vaccine Study Group.

Lancet. 2008 Apr 5;371(9619):1181-9. doi: 10.1016/S0140-6736(08)60524-3.

PMID:
18395579
18.

Current topics in computer-aided drug design.

Taft CA, Da Silva VB, Da Silva CH.

J Pharm Sci. 2008 Mar;97(3):1089-98. doi: 10.1002/jps.21293. Review.

PMID:
18214973
19.

Molecular dynamics, flexible docking, virtual screening, ADMET predictions, and molecular interaction field studies to design novel potential MAO-B inhibitors.

Braun GH, Jorge DM, Ramos HP, Alves RM, da Silva VB, Giuliatti S, Sampaio SV, Taft CA, Silva CH.

J Biomol Struct Dyn. 2008 Feb;25(4):347-55.

PMID:
18092829
20.

Supplemental Content

Loading ...
Support Center